Looking Ahead To 2012: ACOs Get In Gear, Accelerating The Need to Prove Biopharma Products' Overall Value In Health Care
Executive Summary
Thirty-two "Pioneer" accountable care organizations began operations with the new year.
You may also be interested in...
Pfizer Sales Force “Reset” Recognizes Realities Of ACO World, Exec Says
Drug company sales forces have an opportunity to play a larger role in assisting ACO organizations to achieve their goals, Pfizer’s John Zgombic pointed out, because focusing only on a transactional sale with the physician “is no longer valid.”
Honing In On Value At Citicorp Healthcare Conference
The value of medicine was a key theme at Citigroup’s Global Healthcare conference in New York, where top executives from Bristol, Sanofi, Pfizer and Lilly, including J&J’s CEO Alex Gorsky participated in Q&As with analysts and attendees.
Reimbursement News, In Brief
Updates on Medicare’s ACO program, drug spending trends and Medicare coverage of IVIG.